肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

终于等到你：进口PD-1单抗开始在国内十五家医院做临床试验（附名单）

2016-04-03 MedSci MedSci原创

临床试验PD-1
关注

PD-1单抗，在过去一年是让多少肿瘤研究人员热血沸腾，让多少患者望穿秋水的“肿瘤抗生素”，终于在国内多家医院开始临床试验。动动手指转一下，也许便有一个生命在你不经意间得到救助。 下面是Nivolumab（抗PD-1抗体）对比多西他赛治疗非小细胞肺癌III期临床试验参研医院名单，期待更多的适应症尽快开展，也期待国产PD1单抗早日进入临床。目前恒瑞医药PD-1单抗临床试验正式在中山大学肿

PD-1单抗，在过去一年是让多少肿瘤研究人员热血沸腾，让多少患者望穿秋水的“肿瘤抗生素”，终于在国内多家医院开始临床试验。动动手指转一下，也许便有一个生命在你不经意间得到救助。

下面是Nivolumab（抗PD-1抗体）对比多西他赛治疗非小细胞肺癌III期临床试验参研医院名单，期待更多的适应症尽快开展，也期待国产PD1单抗早日进入临床。目前恒瑞医药PD-1单抗临床试验正式在中山大学肿瘤防治中心启动，即将招募实体瘤患者。

姓名 吴一龙 职称 主任医师
电话 020-83800372 Email syylwu@live.cn
邮政地址 广东省广州市中山二路106号伟伦楼14楼 邮编 510080
单位名称 广东省人民医院肿瘤中心肺科

各临床试验医院名单

序号 机构名称 主要研究者 城市 联系电话 门诊
1 广东省人民医院 吴一龙 广州
周三上午
2 吉林省肿瘤医院（吉林省长春市朝阳区湖光路1018号肿瘤科医生办公室） 程颖 长春 0431-85513379 周一上午
3 中山大学肿瘤防治中心（广州市东风东路651号中山肿瘤医院肿瘤内科） 张力 广州 020-87342288/020-87343458 周一周四上午
4 浙江省肿瘤医院（杭州市半山街道半山桥广济路38号，肿瘤内科） 张沂平 杭州
周一全天
5 浙江大学医学院附属第一医院（杭州市庆春路79号，呼吸内科） 周建英 杭州 021-22200000-3115 周一下午周四上午
6 浙江大学医学院附属邵逸夫医院（杭州庆春东路3号，呼吸内科） 应可净 杭州
周一上午周三上午庆春园区，周二上午下沙院区
7 复旦大学附属肿瘤医院（徐汇区东安路270号，肿瘤内科） 常建华 上海
周三上午
8 湘雅医院（长沙市湘雅路87号，呼吸科） 胡成平 长沙
周一全天周二上午
9 江苏省肿瘤医院（南京市百子亭42号，肿瘤内科） 冯继锋 南京
周二下午
10 北京胸科医院（北京市通州区北马厂97号，肿瘤内科） 刘喆 北京
周四上午
11 上海市胸科医院（上海市淮海西路241号，肺部肿瘤临床医学中心） 陆舜 上海
周一下午周四上午
12 上海市肺科医院（上海杨浦区政民路507号2号楼9F，肿瘤科） 周彩存 上海 021-65115006 周一周二上午
13 河南省肿瘤医院（东明路127号，内科） 马智勇 郑州 0371-65588420、0371-65587013 周一上午周三下午周五上午
14 中国人民解放军第三军医大学第三附属医院（大坪医院）（重庆市渝中区大坪长江支路10号，肿瘤科） 王东 中国
周一上午
更多疾病相关的受试者招募，请点击：受试者招募

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2017-09-22 1201f658m10(暂无昵称)

    15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2017-09-19 坚强的土豆啊

    今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2017-09-13 117.140.217.195

    广西的可以参加临床实验吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2017-09-12 忧优

    湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2017-08-14 牛生

    可以参加临床试验吗

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2017-08-06 diiiin

    请问上海的还需要招募临床病人吗？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2017-01-17 ms3297076796458174

    #附名单#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2016-10-04 Carlos007

    也是挺好的

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2016-06-13 1def88e4m69(暂无匿称)

    在其他领域中的应用呢

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=246505, encodeId=581724650502, content=15年确诊肺鳞癌3A期，现在转移对侧可以入组吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=066c2155719, createdName=1201f658m10(暂无昵称), createdTime=Fri Sep 22 06:48:23 CST 2017, time=2017-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=245758, encodeId=d4c5245e58fe, content=今年父亲四月份诊断出肺癌，现在还没出现多发骨转移，可以加入长春临床试验嘛, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e292153628, createdName=坚强的土豆啊, createdTime=Tue Sep 19 20:48:15 CST 2017, time=2017-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243579, encodeId=1eac2435e956, content=广西的可以参加临床实验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=117.140.217.195, createdTime=Wed Sep 13 15:12:09 CST 2017, time=2017-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=243225, encodeId=a831243225ff, content=湖南长沙雨花区的，49岁，男，今年7月查出直肠癌肝转移想参加临床实验，请回复。谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/D449E2B0B25815A0ABFDFC8B120F28BB/100, createdBy=a6b22147193, createdName=忧优, createdTime=Tue Sep 12 14:01:36 CST 2017, time=2017-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=233482, encodeId=f3412334824b, content=可以参加临床试验吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b56a2110555, createdName=牛生, createdTime=Mon Aug 14 13:49:25 CST 2017, time=2017-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=230645, encodeId=f726230645d6, content=请问上海的还需要招募临床病人吗？, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29552105089, createdName=diiiin, createdTime=Sun Aug 06 08:36:45 CST 2017, time=2017-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1818567, encodeId=4b31181856e43, content=<a href='/topic/show?id=2c019e96631' target=_blank style='color:#2F92EE;'>#附名单#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97966, encryptionId=2c019e96631, topicName=附名单)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/vLodSSFTQLpHtfwJicWJibSWH7pbiauxvpCMvQIv0N9Oes8vHkDkCIW2HNDkt7icUq3RCZiaDcHR9Rap17fFySRbiaFg/132, createdBy=9f202500205, createdName=ms3297076796458174, createdTime=Tue Jan 17 06:28:00 CST 2017, time=2017-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=139890, encodeId=cb42139890ee, content=也是挺好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160923/IMG57E54D670B3C08868.jpg, createdBy=e90b1956497, createdName=Carlos007, createdTime=Tue Oct 04 12:03:36 CST 2016, time=2016-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89748, encodeId=c1fd89e48c7, content=在其他领域中的应用呢, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:20:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89747, encodeId=350e89e479a, content=没有安徽的吗, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54221735253, createdName=1def88e4m69(暂无匿称), createdTime=Mon Jun 13 14:19:00 CST 2016, time=2016-06-13, status=1, ipAttribution=)]
    2016-06-13 1def88e4m69(暂无匿称)

    没有安徽的吗

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

药品临床试验数据最残酷核查开始，有几家能扛得住？

3月29日，国家食品药品监督管理总局（简称“总局”）下发了《总局关于印发药物临床试验数据核查工作程序（暂行）的通知》（简称“通知”），这意味着从2015年7月开始的药物临床试验数据核查收紧工作迎来了最“残酷”的高潮。为什么说它残酷？让我们逐一分析。首先，核查对数据真实完整的要求非常苛刻。根据总局官网发布的《药物临床试验数据现场核查要点》（简称“要点”），核查将对所有数据的可溯源性和真实有效性进

JAMA：临床试验数据使用OA平台的状况调查不容乐观

对临床试验报告偏倚的担忧激发呼吁更多的开放性数据分享。作为回应，多家药企公司给研究者开发了工具以获取病人水平的临床数据。然而，这些分享的临床数据是否以及如何使用的尚不清楚。我们通过3个OA平台（ClinicalStudyDataRequest.com,YODA,SOAR,）来评估有多少临床试验是向公众开放的。这些平台的赞助商数据包括：葛兰素史克、阿斯特拉,勃林格殷格翰公司,卫材,礼来,诺华,罗氏公

JCO：临床试验中OS还是金标准吗？

 随机对照临床试验（randomized controlled trials，RCT）是评价治疗对于患者结局的金标准。传统上来看，一种治疗方案是否有效取决于三期临床试验是否显著延长了总的生存时间（OS）或者改善了生活治疗。但是使用OS这一指标作为主要终点就要求临床试验要有大量的病人参与其中，并且对病人的随访会带来巨大的支出。因此，OS结果常常受到研究后治疗和交叉设计的影响。其他的终点，比

中国CDE临床试验登记与信息公示平台：常见问题分析

 2013年9月6日，国家食品药品监督管理总局发布2013年第28号公告，要求“凡获国家食品药品监督管理总局临床试验批件并在我国进行临床试验（含生物等效性试验、药代动力学试验、I、Ⅱ、Ⅲ、Ⅳ期试验等）的，均应登陆信息平台，按要求进行临床试验登记与信息公示”。 本平台按照上述公告执行试验登记的各项要求，包括要求登记试验的范围和类型、登记时间等。在“药物临床试验登记与信息公示”平台（w

CFDA将对16个药物临床试验数据现场核查，会延续7.22惨案吗？

继3月29日国家食药监总局公布《国家食品药品监督管理总局药物临床试验数据核查工作程序（暂行）》后，昨日（3月30日），国家食品药品审核查验中心紧接着发布《药物临床试验数据现场核查计划公告（第1号）》。 根据审核查验中心公告，国家食药监总局计划对富马酸贝达喹啉片等16个药物临床试验数据自查核查品种开展现场核查。公示期为 10 个工作日，即2016年3月30日至4月13日，公示期结束后，将按

CFDA正式印发药物临床试验数据核查工作程序（暂行）的通知

3月29日，CFDA正式印发了《国家食品药品监督管理总局药物临床试验数据核查工作程序（暂行）》，此前2月24日，CFDA曾发布《关于征求药物临床试验数据核查工作程序意见的通知》征求意见，相比较于意见稿，此次发布的《工作程序（暂行）》，出现了两点变化：第四点中“注册申请人在10日内没有提出撤回申请的视为接受现场核查，此后不再接受药品注册申请人的撤回申请，核查中心将派出检查组现场核查”改为了“药品注册